These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 15992136)

  • 1. Levobupivacaine: a new safer long acting local anaesthetic agent.
    Gristwood RW; Greaves JL
    Expert Opin Investig Drugs; 1999 Jun; 8(6):861-76. PubMed ID: 15992136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac and CNS toxicity of levobupivacaine: strengths of evidence for advantage over bupivacaine.
    Gristwood RW
    Drug Saf; 2002; 25(3):153-63. PubMed ID: 11945112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levobupivacaine: a review of its pharmacology and use as a local anaesthetic.
    Foster RH; Markham A
    Drugs; 2000 Mar; 59(3):551-79. PubMed ID: 10776835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levobupivacaine.
    McClellan KJ; Spencer CM
    Drugs; 1998 Sep; 56(3):355-62; discussion 363-4. PubMed ID: 9777312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiotoxicity with modern local anaesthetics: is there a safer choice?
    Mather LE; Chang DH
    Drugs; 2001; 61(3):333-42. PubMed ID: 11293644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levobupivacaine.
    Ivani G; Borghi B; van Oven H
    Minerva Anestesiol; 2001 Sep; 67(9 Suppl 1):20-3. PubMed ID: 11778089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complications and local anaesthetic toxicity in regional anaesthesia.
    Veering BT
    Curr Opin Anaesthesiol; 2003 Oct; 16(5):455-9. PubMed ID: 17021497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Pharmacokinetics and Pharmacodynamics of Levobupivacaine.
    Heppolette CAA; Brunnen D; Bampoe S; Odor PM
    Clin Pharmacokinet; 2020 Jun; 59(6):715-745. PubMed ID: 32034727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central blocks with levobupivacaina in children.
    Ingelmo PM; Fumagalli R
    Minerva Anestesiol; 2005 Jun; 71(6):339-45. PubMed ID: 15886598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy and safety of 0.75% levobupivacaine vs 0.75% bupivacaine for peribulbar anaesthesia.
    Birt DJ; Cummings GC
    Eye (Lond); 2003 Mar; 17(2):200-6. PubMed ID: 12640407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on ropivacaine.
    Wang RD; Dangler LA; Greengrass RA
    Expert Opin Pharmacother; 2001 Dec; 2(12):2051-63. PubMed ID: 11825334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in the pharmacokinetics of local anaesthetics. Long-acting amide enantiomers and continuous infusions.
    Thomas JM; Schug SA
    Clin Pharmacokinet; 1999 Jan; 36(1):67-83. PubMed ID: 9989343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Levobupivacaine in obstetric analgesia and anaesthesia. Where is its place?].
    Bremerich DH; Zwissler B
    Anaesthesist; 2004 Jul; 53(7):637-44. PubMed ID: 15221118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of sufentanil on minimum local analgesic concentrations of epidural bupivacaine, ropivacaine and levobupivacaine in nullipara in early labour.
    Buyse I; Stockman W; Columb M; Vandermeersch E; Van de Velde M
    Int J Obstet Anesth; 2007 Jan; 16(1):22-8. PubMed ID: 17125998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of intrathecal bupivacaine and levobupivacaine combined with opioids for Caesarean section.
    Bremerich DH; Fetsch N; Zwissler BC; Meininger D; Gogarten W; Byhahn C
    Curr Med Res Opin; 2007 Dec; 23(12):3047-54. PubMed ID: 17967219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The local anaesthetic activity of levobupivacaine does not differ from racemic bupivacaine (Marcain): first clinical evidence.
    Bardsley H; Gristwood R; Watson N; Nimmo W
    Expert Opin Investig Drugs; 1997 Dec; 6(12):1883-5. PubMed ID: 15989589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levobupivacaine absorption pharmacokinetics with and without epinephrine during TAP block: analysis of doses based on the associated risk of local anaesthetic toxicity.
    Miranda P; Corvetto MA; Altermatt FR; Araneda A; Echevarría GC; Cortínez LI
    Eur J Clin Pharmacol; 2016 Oct; 72(10):1221-1227. PubMed ID: 27417947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benefit-risk assessment of ropivacaine in the management of postoperative pain.
    Zink W; Graf BM
    Drug Saf; 2004; 27(14):1093-114. PubMed ID: 15554745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ropivacaine: a pharmacological review.
    Hansen TG
    Expert Rev Neurother; 2004 Sep; 4(5):781-91. PubMed ID: 15853505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct cardiac effects of intracoronary bupivacaine, levobupivacaine and ropivacaine in the sheep.
    Chang DH; Ladd LA; Copeland S; Iglesias MA; Plummer JL; Mather LE
    Br J Pharmacol; 2001 Feb; 132(3):649-58. PubMed ID: 11159717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.